Metrion Biosciences Limited and LifeArc have entered into a collaboration agreement for an ion channel drug discovery project in the field of neuroscience.    The project aims to identify novel selective small molecule modulators of a specific ion channel target, which human patient gene association studies have identified as likely to be involved in neurological pathogenesis.   LifeArc will have responsibility for all new chemical syntheses with Metrion conducting ion channel screen...